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Normal formation of the placenta and access to the maternal arterial blood supply determine 5 reproductive success. Indeed, major complications of pregnancy such as pre-eclampsia and fetal growth restriction have their origins in very early pregnancy 1 . During pregnancy, the endometrium is transformed to decidua under the influence of progesterone secreted by the corpus luteum. Decidualisation results from a complex but well-orchestrated cellular differentiation program including enlargement of the stromal cells, increase in secretory 10 activity of the glandular cells, and the expansion of the dominant immune population in the decidua, the distinctive decidual NK cells (dNK) 2 .
Following implantation of the blastocyst through the surface epithelium, placental trophoblast cells invade through the decidua and move towards the spiral arteries, where they destroy the smooth muscle media to transform the arteries into high conductance vessels 3 . 15
Extravillous trophoblast (EVT) migrates right through the decidua and reaches as far as the inner myometrium. Balanced regulation of EVT invasion is critical to pregnancy success:
arteries must be sufficiently transformed, but excessive invasion prevented, to ensure correct allocation of resources to both mother and baby. The decidua plays a key role in regulating invasion and when it is absent, for example when the placenta implants on a previous 20 cesarean section scar, trophoblast invades uncontrollably, threatening the viability of the pregnancy and maternal wellbeing. 4, 5 .
The different cellular components of decidua all support the establishment of early pregnancy in human. Decidual glands provide histiotrophic nutrition to the placenta before the arterial connections are established 6, 7 . Stromal cells generate a rich extracellular matrix 25 (ECM), that facilitates EVT invasion, and secrete products such as prolactin and insulin-like growth factor-binding protein 1 (IGFBP-1) 2 . Damaging allogenic responses of decidual T cells to EVT are prevented by immune suppressive mechanisms. The major decidual immune population, dNK, recognise and respond to EVTs using a range of receptors including maternal killer immunoglobulin-like receptors (KIR), which recognise the sole polymorphic 30 5 of the combined dataset and used cluster-specific marker genes to annotate the clusters (Fig. 1d-f, Extended Data Fig. 1-2 ). Cells were confirmed as being fetal or maternal in origin by 70 evaluating scRNA-seq reads overlapping single nucleotide polymorphisms (SNPs) called from maternal or fetal genomic DNA (Fig. 1g , Extended Data Fig. 1c-d ). Decidua and placenta were mainly comprised of maternal and fetal cells respectively, however there were small numbers of fetal HLA-G+ EVTs present in the decidua, and maternal myeloid cells (MP3 cluster) were detected in the placenta; these are likely to be patrolling maternal 75 monocytes that attach to the syncytial surface 11 .
The decidua is composed of glands, vessels, stroma, and immune cells. Differentially expressed genes allowed us to identify subpopulations as follows (Fig. 1f, Extended Data Fig.   2 ). The cluster of decidual glandular epithelial cells is characterized by high levels of the epithelial marker EPCAM and the progestagen associated endometrial molecule (PAEP). We 80 identify endothelial cells expressing CD34 and CD31 antigen (PECAM1). A heterogeneous population of fibroblasts express matrix protein genes (e.g. PCOLCE, COL6A2) and is negative for PAEP, CD45, and CD31. We reveal the presence of three dNK subsets (the most prevalent immune populations), two macrophage subsets, one dendritic cell subset (DC1).
Decidual CD4+ and CD8+ T cells cluster together (Fig. 1e) . 85
In the placenta, we identify trophoblast cells, which lack the expression of histocompatibility complex A (HLA-A) and B (HLA-B) and fetal fibroblasts expressing the notch ligand DLK1, known to be present in the core of the placental villi 11 (Fig. 1f , Extended
Data Fig. 2 ). We identify the placental myeloid cells, Hofbauer cells, which express lymphatic endothelial marker LYVE-1 and the CD14 molecule 12 . 90
Placental trophoblast cells differentiate along two main pathways
Placental development is characterised by fetal trophoblast differentiation into EVTs and syncytiotrophoblast (SCT). The molecular transition and regulation of this process in humans is poorly characterised. We leveraged our scRNA-seq dataset to reconstruct the 95 developmental relationship of all trophoblast cells present in both placental and decidual samples using the pseudotime trajectory algorithm Monocle 2 13 . In agreement with previous reports 14 , we resolved two distinct pathways for SCT and EVT differentiation (Fig. 2a ).
Villous cytotrophoblasts (VCTs) fuse to become SCT and this is mediated by expression of Syncytin-2 (ERVFRD-1) binding to its receptor MFSD2A. We observed a 100 population of cells expressing ERVFRD-1 prior to SCT fusion (Fig. 2b) . Furthermore,
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ERVFRD-1 expression declines in cells expressing the receptor MFSD2A at the end of the SCT differentiation trajectory, indicating some syncytial cells are present. HLA-G+ EVT are most abundant in placental samples with small numbers in decidua (Fig. 2a) . In our placental
isolates, approximately 40% of HLA-G+ EVT express the cell cycle gene MCM2; in contrast, 105 none of the decidual EVT are cycling. Our analysis of trophoblast differentiation reveals the transcription factors (TFs) involved in the differentiation of EVTs and SCT fusion. The data confirms involvement of the TF OVOL1 15 and predicts many new factors involved in trophoblast fusion (Fig. 2c , Extended Data Fig. 3 ). Our pseudotime reconstruction also captures a proliferative trophoblast population (Fig. 2b) , characterised by expression of 110 ITGA2, SCD5 and EPCAM as described previously 16 .
Little is known about differentiation of EVTs as they migrate into the decidua. To investigate decidual EVTs further, we enriched for HLA-G+ CD45-EVT cells in the decidua and performed SS2 scRNA-seq from an additional five decidual samples (Extended Data Fig.   4 ). We then compared the transcriptomes of placental EVTs (in the cytotrophoblast cell 115 columns) with decidual EVTs (interstitial trophoblast). This reveals a number of cell communication and adhesion molecules, as well as hormones characterising decidual EVTs (Fig. 2d) . Other molecules that are upregulated as EVTs invade include: the IGFBP dependent molecule PAPPA, PAPPA2, and the tyrosine kinase FLT1. These are all potential biomarkers used to predict pregnancy complications 17, 18 . 120
Heterogeneity of stromal and glandular epithelial cells defines two decidual layers
We describe five clusters of decidual fibroblast cells (dFB1-5), expressing extracellular matrix molecules (e.g. PCOLCE, COL6A2) and lacking markers for endothelial cells (CD34), trophoblast (HLA-G) and epithelial cells (EPCAM) (Fig. 3a, Extended Data Fig. 5 ). dFB1 125 cells express the canonical pericyte markers MCAM (CD146) and PDGFRB (CD140b), as well as RENIN and RGS5, both involved in regulating vascular tone (Fig. 3b) . The dFB2 population shares an expression pattern with dFB1, such as smooth muscle genes (e.g.
MYH11)
, and the matrix protein MGP. dFB2 cells also have features of specialised smooth muscle cells involved in tissue remodelling, with higher levels of the matrix metalloprotease 130 MMP11 and the cathepsin CTSK.
The dFB3-5 cell populations all express the WNT inhibitor DKK1, known to mark decidual stromal cells 19 . dFB3 shares myofibroblast features with dFB1/2 showing high levels of smooth muscle ACTA2 and TAGLN with dFB1/2. Members of the insulin growth 7 factor (IGF) family are differentially expressed in the dFB3-5 subsets, with dFB3 expressing 135 higher levels of IGF1/2, and dFB4/5 expressing high levels of IGFBP1/2/6. In contrast, the dFB4/5 populations are decidualised stromal cells, expressing higher levels of the metallopeptidase inhibitor TIMP3 and IGFBP1 with dFB5 expressing high levels of the pregnancy hormone prolactin (PRL), used as a marker of decidualisation in vitro. dFB5 cells express the cell cycle inhibition protein ING1, further supporting this population as being the 140 most differentiated. Pseudotime analysis predicts a differentiation trajectory from dFB1 to dFB5, positioning dFB5 at one end of the progression (Extended Data Fig. 6 ). This trajectory links the three dFB3-5 populations as expected. More surprisingly, it suggests possible interrelationships between and plasticity across all five dFB subpopulations. The pericyte-like population (dFB1), is positioned at the other end of the trajectory, confirming reports that 145 pre-decidual stromal cells express pericyte markers cells 20 . Indeed, dFB1 cells seem able to self-renew as they express genes involved in cell proliferation and development (e.g. TPPP3
and NOTCH3).
Steroid hormones play an important role in pregnancy [21] [22] [23] , however their presence cannot be directly measured by gene expression analysis, as they are organic compounds 150 rather than proteins. Instead, we analysed expression of the steroid biosynthesis pathway genes. Enzymes involved in cholesterol synthesis are upregulated in dFB3/4, and downregulated in dFB5, which expresses enzymes involved in pregnenolone synthesis (Fig.   3c ). This suggests that, during differentiation from dFB3/4 to dFB5, a metabolic transition occurs, such that dFB5 cells synthesize both steroids and prolactin. 155
Pericytes and smooth muscle cells (dFB1/2) encircle vessels, whilst stromal cells (dFB3-5) are located throughout the decidua, in close contact with maternal immune cells and invading EVTs. The gradual increase of decidualisation molecules in dFB4/5 suggest a microanatomical zonation, and a distinct distribution of dFB3 and dFB4/5 within the decidua.
Histologically, the decidua is divided into two morphological zones: decidua spongiosa close 160 to the myometrium, and the more superficial decidua compacta. In order to locate the stromal subsets (dFB3-5), we stained tissue sections for the marker ACTA2, expressed by dFB3 and downregulated in dFB4/5 (Fig. 3d) . ACTA2 expression clearly divides the decidua stroma into two defined layers corresponding to the decidua spongiosa (dFB3) and compacta (dFB 4/5). 165
The EPCAM+ epithelium of uterine glands present is also histologically distinguishable in the two decidual layers. In the decidua spongiosa glandular cells are 'plump', with abundant cytoplasmic content, described as hypersecretory 24 . In contrast, in decidua compacta the glandular epithelium forms a thin layer, and appears 'exhausted'. Our single-cell transcriptomics analysis resolves two different glandular epithelial cell clusters; 170 one expressing transporters (e.g. FXYD2, MT1G), suggestive of more active metabolism and high secretory function of spongiosa cells, and the other with high expression of mitochondrial genes and molecules involved in autophagy (e.g. TMEM49) (Fig. 3e) .
By integrating scRNA-seq with histology, we assign the location of the stromal and glandular epithelial cells to specific microanatomical zones within human decidua (Fig. 3f) . 175
Immune cell profile in the decidua during early pregnancy
To further define the heterogeneity of maternal decidual immune cells and evaluate TCR and KIR receptor sequences, we generated a full-length transcript scRNA-seq dataset using our robotic SS2 platform. We profiled 4,248 CD45+ cells in decidua and 1,262 cells from 180 maternal blood, isolated using antibodies against proteins characteristic of decidual immune (Fig. 4c,  200 Extended Data Fig. 8b ).
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The myeloid compartment in the decidua is composed of two macrophage populations characterized by high expression levels of CD14 and MHCII genes. These two populations are distinct in terms of their expression of CD11C, termed CD11C hi dMP1 and CD11C lo dMP2. We identify two populations of dendritic cells (DC) expressing classical markers for 205 DC1 and DC2 (Fig. 4d) . Mast cells are a minor population (~0.5% of total immune cells in the decidua).
The dMP1 CD11C
hi population shares genes with decidual monocytes (e.g., S100A9), 
220

Three main decidual natural killer (dNK) subsets
The dominant population of immune cells in the first trimester decidua are CD56+ NK cells, expressing tissue resident markers CD49a (ITGA1) and CD9 (Extended Data Fig. 8a ). We computationally identify three main subsets of decidual NK cells (dNK1-3), which are all distinct from peripheral blood NK cells (Fig. 4a) . The markers that best discriminate between 225 dNK1-3 clusters are: the surface protein CD39 (ENTPD1) and the transcription factor ID3 for dNK1 cells; the annexin member ANXA1 and the integrin ITGB2 for dNK2 cells; and chemokine receptor CXCR4 and the glycoprotein CD160 for dNK3 cells (Fig. 4f) . It is noteworthy that the dNK3 population exhibits features of ILC1-like cells, so we call them dNK3/dILC1. The typical ILC1 markers that are expressed in these cells are TBX21, CD160, 230 CD161 (KLRB1) and CD103 (ITGAE), but they are negative for CD127 (IL7R) (Extended Data Fig. 8a ).
The two dNK populations, dNK1 and dNK2, differ in the content of their secretory granules, only expressed at low levels in dNK3/dILC1 cells. dNK1 express high levels of cytotoxic granule molecules (GNLY, GZMA, GZMB), whilst dNK2 and dNK3/dILC1 are 235 characterised by the unconventional granzymes GZMH and GZMM (Fig. 4g) . It is interesting to note that dNK1 cells express CYP26A1, known to alter the composition of murine dNK subsets 31 (Fig. 4f) .
Receptors of the Killer-cell immunoglobulin-like Receptor (KIR) family that bind to HLA class I molecules, and other NKR binding to EVT ligand, are differentially expressed 240 on dNK1 and dNK2 cells. KIR recognise polymorphic HLA-C allotypes, and, because KIR family members are also polymporphic and highly homologous, quantifying expression of individual KIR genes is challenging 9 . To solve this problem, we used our full-length transcript SS2 data to map each donor's single cell reads to the corresponding donor-specific reference of KIR alleles, based on existing haplotypes (see Methods). The levels of 245 expression of the specific KIR receptors that interact with HLA-C (KIR2DL1/DL2/DL3 and KIR2DS1/DS4), and the HLA-G-binding receptor LILRB1, are high on dNK1, low on dNK2, and absent on dNK3/dILC1 (Fig. 4h) . Both dNK1 and dNK2 have high levels of the HLA-E interacting receptors (KLRC1, KLRC2, KLRC3), which include both activating and inhibitory receptors (inhibitory KLRC1, activating KLRC2 and KLRC3). 250
In summary, our transcriptomic analysis reveals three subsets of dNK cells with potentially different regulatory, inhibitory and cytotoxic capacity.
dNK subsets have distinct receptor-ligand interactions
Many of the decidual cell populations described above express specific cell surface receptor 255 and ligand molecules, which we curate in CellPhoneDB. We take into account the expression levels of ligands and receptors within each cell type, and calculate statistically significant ligand-receptor pairs by empirical shuffling (Fig. 5a ). This way, we predict functional interactions between cell populations via specific protein complexes. Here we focus on receptors and ligands that are differentially expressed by dNK subsets to predict their 260 significant cellular interactions (Fig. 5b) .
Our analysis reveals more potential interactions for dNK1 with EVTs than for the two other dNK populations (39 dNK1 vs 33 dNK2 and 30 dNK3/ILC1). This suggests that EVTs preferentially bind the dNK1 subset (Fig. 5c ). Specific interactions include LILRB1 -HLA-G and KIRs -HLA-C. The physical proximity between dNK1 and EVT in the decidua basalis is 265 confirmed by IHC of serial sections stained for CK7 (EVT) and KIR2DL1 (dNK1) (Fig. 5d ).
In addition, our method predicted different growth factor and chemokine interactions for dNK1/2 and dNK3/dILC1 cells. dNK1 expresses higher levels of the cytokine CSF1, whose receptor, CSF1R, is expressed by EVTs and macrophages (Fig. 5e ). Secretion of CSF1 by dNK cells, and the impact of their interaction with the CSF1R on EVT has been 270 described 32, 33 . We are now able to pinpoint that this interaction is mediated specifically by the dNK1 subset.
In contrast, dNK2-3 express low levels of CSF1, and high levels of XCL1 and CCL5.
EVT strongly express the chemokine-scavenging receptor ACKR2 34 , that binds numerous inflammatory CC-chemokines, including CCL3, 4 and 5 (Fig. 5e ). ACKR2 acts as a decoy 275 receptor, effectively putting a brake on the inflammatory response 35, 36 . CCL5 also binds the chemokine receptor CCR1 expressed by EVT, and may regulate EVT migration into the decidua 37 . XCL1 binds the XCR1 receptor expressed by both EVT and decidual myeloid cells.
Multiple anti-inflammatory, tolerogenic interactions at the maternal-fetal interface 280
The diversity and large number of receptor-ligand interactions between EVT and decidual cells must relate to the development of an anti-inflammatory, tolerogenic environment, critical for the peaceful compromise needed to define the territorial boundary between mother and fetus. We use CellPhoneDB to predict tolerogenic crosstalk in the maternal-fetal interface and identify the following statistically significant interactions. Interactions between 285 EVT and dNK1 include the CD200R1 on dNK1, potentially interacting with CD200 expressed by EVT (Fig. 5b, 6a ). EVTs also express inhibitory receptors, CLEC2D and PVR, whose ligands KLRB1 and TIGIT are highly expressed on dNK2 and dNK3 respectively, providing additional NK-EVT interactions that could inhibit NK killing of EVTs.
We predict that EVT cells interact specifically to suppress T cell responses. As 290 mentioned above, the clonal expansion of decidual CD8+ T cells suggests they are responding to local APCs, and CD8+ T cells express the gene PD1. We note the high expression of PDL1 in the EVT, which we confirm by IHC on serial sections stained for PDL1 and HLA-G (Fig. 6d) . No other cells in the decidua are PDL1+, as shown by our IHC analysis of decidua parietalis away from the implantation site. 295
We hypothesize that the three differentiated stromal cell populations dFB3-5 also play an important role in contributing to the anti-inflammatory environment of the decidua (Fig.   6c ). In the superficial decidua compacta where EVTs first invade, dFB4/5 cells express high levels of Galectin-9 (LGALS9), with the cognate receptor TIM3 expressed on dCD8+ T cells and dNK1/2 cells. Like EVT cells, dFB4/5 cells express high levels of the c-type lectin 300 (CLEC2D), whose ligand KLRB1 is expressed on dNK2 and dNK3/dILC1 cells (Fig. 5b) . The steroid biosynthesis in dFB5 cells may also contribute to the tolerogenic environment in the decidua compacta.
In addition to EVT and stromal cells, immune subsets themselves also contribute to the tolerogenic environment. For instance, dNK1 cells express SPINK2, an inhibitor of 305 inflammatory and secreted kallikrein molecules 38 , and dNK2/3 express high levels of the annexin member ANXA1, with anti-inflammatory roles. The dNK1 subset also express ENTPD1 (CD39), which together with CD73 (NT5E) converts ATP to adenosine, a small molecule known to abrogate immune activation 39 . The expression of CD73 is high in epithelial glands and EVTs, and the adenosine receptor (ADORA3) is found on decidual 310 myeloid cells (Fig. 5b, 6c ).
In summary, both EVT and stromal cells, as well as innate immune cell populations, all contribute to setting up an anti-inflammatory environment at the site of placentation in early pregnancy. This is mediated by multiple classes of signalling molecules: cell surface tethered receptor-ligand complexes, secreted proteins, as well as small molecules (adenosine 315 and steroid hormones).
Discussion
Healthy pregnancy depends on the normal growth and development of the placenta in the first trimester, yet the cellular and molecular events occurring in the uterus are still not understood. Difficulties in accessing material and the absence of reliable in vitro models 40 , as 320 well as substantial differences between human and rodent models, have hindered progress.
Here, we overcome some of these limitations by profiling human placental and decidual tissue from early pregnancy (6-14 weeks) using a combination of scRNA-seq methods. By integrating this data with maternal and fetal whole genome sequencing, we can assign the fetal and maternal genotype of each individual cell. Thus, we are able to evaluate the 325 contribution of maternal and fetal cells within both the placenta and decidua, and generate an unbiased map of this important tissue interface highlighting new cell states (Fig. 6e ).
Trophoblast cells, derived from trophectoderm, are extra-embryonic cells providing a physical barrier between mother and fetus. In contrast to other studies that have focused on term placental tissue 14,41 , we have analysed trophoblast cells in early pregnancy at the time 330 the placenta expands and becomes established. We were, for the first time, able to resolve 13 trophoblast development into a tri-partite branching trajectory using first trimester samples, and confirmed that in humans there is differentiation along two main lineages, EVT and SCT.
Genes known to be involved in fusion of VCT into the overlying syncytial layer are highly expressed at the end of the SCT trajectory. Our differential expression analysis along the 335 trajectory allowed us to identify novel TFs involved in trophoblast differentiation and fusion.
By comparing the HLA-G+ EVT cells from the placental villi with HLA-G+ cells isolated from decidual tissue, we highlight genes that are upregulated during the invasive process.
These include genes such as PAPPA and FLT1; low PAPPA levels in maternal serum are associated with pregnancy disorders caused by poor trophoblast invasion and defective 340 placentation 16, 17 .
The combination of single-cell transcriptomics and spatial in situ methods provide a unique framework to study the microanatomical distribution of cells in the tissue 42, 43 . We resolved five decidual fibroblasts subsets (dFB1-5) and two epithelial glands that we located in the two layers of the decidua, spongiosa and compacta. Two populations, dFB1 and dFB2, 345 and IL7R (CD127) expression. dNK1 are of particular interest since they express NK 360 receptors that bind to HLA-C, HLA-G and HLA-E expressed by EVT 40 . We show high expression of cytotoxic molecules of secretory granules for dNK1, although the lack of expression of b2 integrin (ITGB2) would reduce their cytotoxic potential 47 . dNK1 cells express high levels of the cytokine CSF1, whose receptor is involved in trophoblast recruitment and activity 32, 33 . 365
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Our cell-cell communication analysis framework indicates that dNK1 cells have a unique regulatory profile. dNK1 cells express the ectonucleotidase CD39 (ENTPD1) which degrades extracellular ATP (eATP) in tandem with CD73 (NT5E), expressed in the nonimmune decidual populations, to promote the synthesis of adenosine that suppresses both innate and adaptive immune responses 48, 49 . dNK2 and dNK3 also express anti-inflammatory 370 molecules like ANXA1, playing key immunoregulatory roles to protect the conceptus and ensure its survival. In addition, dNK2-3 express high levels of the cytokines CCL5 and XCL1, with their receptors present on trophoblast cells, myeloid and DC1 cells. Binding of XCL1 to XCR1 has been implicated in the recruitment of DC1s in other contexts 50 . This is consistent with our observation of expanded DC1 compared to DC2 in the decidua, in contrast to other 375 tissues where DC2 vastly outnumber DC1 51, 52 . In summary, we present a single cell resolution atlas of the human maternal fetal interface, describing a range of novel cell subsets, their developmental trajectories, and surface receptors potentially mediating critical interactions between cell populations. The methods and database we have created, publicly available at www.CellPhoneDB.org, will be 380 widely applicable to study cell-cell communication in other systems. This study identifies many novel molecular and cellular mechanisms that are operating at the fetal-maternal interface, and these insights may improve the diagnosis and treatment of infertility and complications of pregnancy. 
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Each first trimester placenta was placed in a petri dish and the placental villi were scraped from the chorionic membrane using a scalpel. The stripped membrane was discarded and the resultant villous tissue was enzymatically digested in 70 ml 0.2% trypsin 250 (Pan 550 Biotech P10-025100P)/0.02% EDTA (Sigma E9884) in PBS with stirring at 37°c for 9 min.
The disaggregated cell suspension was passed through sterile muslin gauze (Winware food grade) and washed through with Hams F12 medium (Biosera SM-H0096) containing 20% FBS (Biosera FB-1001). Cells were pelleted from the filtrate by centrifugation and resuspended in Hams F12. The undigested, gelatinous tissue remnant was retrieved from the 555 gauze and further digested with 10-15 ml collagenase V at 1.0mg/ml (Sigma C9263) in Hams F12 medium/10% FBS with gentle shaking at 37°C for 10 min. The disaggregated cell suspension from collagenase digestion was passed through sterile muslin gauze and the cells pelleted from the filtrate as before. Cells obtained from both enzyme digests were pooled together and passed through 100um cell sieve (Corning, 431752) and washed in Hams F12. 560
The flow-through was centrifuged and resuspended in 5ml of red blood cell lysis buffer (Invitrogen, 00-4300) for 10min.
Blood samples were carefully layered onto a Ficoll-paque gradient (Amersham, Buckinghamshire, UK) and centrifuged at 2,000 rpm for 30 min without brakes. Peripheral blood mononuclear cells (PBMCs), from the interface between the plasma and the Ficoll-565
Paque gradient, were collected and washed in ice-cold phosphate-buffered saline (PBS), followed by centrifugation at 2,000 rpm for 5 min. The pellet was resuspended in 5ml of red blood cell lysis buffer (Invitrogen, 00-4300) for 10min.
Flow cytometry staining, cell sorting and single-cell RNA sequencing 570
Decidual and blood cells were incubated at 4°C with 2.5ul of antibodies in 1% FBS in DPBS without Calcium and Magnesium (ThermoFisher Scientific, 14190136). DAPI was used for live/dead discrimination. We used an antibody panel designed to enrich for certain population for single-cell sorting and single-cell RNA sequencing (scRNA-seq). Cells were sorted using a Becton Dickinson (BD) FACS Aria Fusion with 5 excitation lasers (355nm, 405nm, 488nm, 575 561nm and 635nm Red), and 18 fluorescent detectors plus forward and side scatter. The sorter was controlled using BD FACS DIVA software (version 7).
For single-cell RNA-seq using the plate-based SS2 protocol, we created overlapping gates that comprehensively and evenly sampled all immune cell population in the decidua (Extended Data Fig 4) . B cells (CD19+ or CD20+) were excluded from our analysis, due to 580 their absence in decidua 56 . Single cells were sorted into 96-well full-skirted Eppendorf plated chilled to 4C, prepared with lysis buffer consisting of 10 ul of TCL buffer (Qiagen)
supplemented with 1% b-mercaptoethanol. Single-cell lysates were sealed, vortexed, spun down at 300g at 4°C for 1 min, immediately placed on dry ice, and transferred for storage at -80°C. The SS2 protocol was performed on single-cells as described previously 58, 59 , with some 585 
Immunohistochemistry (IHC)
Tissue sections of 4um were cut from formalin-fixed paraffin wax-embedded human decidual and placental tissues. Sections were dewaxed with Histoclear, cleared in 100% ethanol and 600 rehydrated through gradients of ethanol to PBS. Sections were blocked with 2% serum (of species in which the secondary antibody was made) in PBS, incubated with primary antibody for overnight at 4 RT°C and slides washed in PBS. Biotinylated horse anti-mouse or goat anti-rabbit secondary antibody were used, followed by vectastain ABC-HRP reagent (Vector, PK-6100) and developed with di-aminobenzidine (DAB) substrate (Sigma, D4168). Sections 605 were counterstained with Carazzi's haematoxylin and mounted in glycerol/gelatin mounting medium (Sigma, GG1-10). Primary antibody was replaced with equivalent concentration of mouse or rabbit IgG for negative controls. Tissue sections were imaged using a Zeiss Axiovert Z1 microscope and Axiovision imaging software SE64 V4.8.
610
Whole genome sequencing
Tissue DNA and RNA were extracted from fresh frozen samples using the AllPrep DNA/RNA/miRNA kit (Qiagen) following the manufacturer's instructions. Libraries for whole-genome sequencing were constructed according to Illumina library protocols, and 100-base paired-end sequencing was performed on HiSeq X genome analysers to an average of 615 30× coverage.
Single cell RNA-seq data analysis
Droplet-based sequencing data was aligned and quantified using the Cell Ranger Single-Cell Software Suite (version 2.0, 10x Genomics Inc) 61 against the GRCh38 human reference 620 genome provided by Cell Ranger. Cells with fewer than 500 detected genes and for which the total mitochondrial expression exceeded 20% were removed. Genes that were expressed in fewer than 3 cells were also removed. SmartSeq2 sequencing data was aligned with HISAT2 62 , using the same genome reference and annotation as the 10x data. Gene-specific read counts were calculated using HTSeq-count 63 . Cells with fewer than 1,000 detected genes 625 and more than 20% mitochondrial content were removed. Further, genes expressed in fewer than 3 cells were also removed.
Downstream analysis such as normalisation, k-nearest neighbour graph clustering, differential expression analysis and visualisation, were performed using the R package Seurat 64 . tSNE analysis was performed using a perplexity of 30. Clusters were annotated 630 using canonical cell type markers. We further removed cells we did not gate for (most likely maternal blood B cells and fetal brain tissue), clusters for which the top markers were genes associated with dissociation-induced effects 65 , or mitochondrial genes, and a fibroblast cluster with high expression of hemoglobin genes due to background contamination of cell free RNA. Droplet-based and SmartSeq2 data were integrated using the Seurat alignment 635 To match the processing of the whole-genome sequencing datasets, droplet-based sequencing data from decidua and placenta samples were realigned and quantified against the GRCh37 650 human reference genome using the Cell Ranger Single-Cell Software Suite (v.2.0) 61 . The fetal or maternal origin of each barcoded cell was then determined using the tool demuxlet 67 .
Briefly, demuxlet can be used to deconvolve droplet-based scRNA-seq experiments in which cells are pooled from multiple, genetically distinct individuals. Given a set of genotypes corresponding to these individuals, demuxlet infers the most likely genetic identity of each 655 droplet by estimating the likelihood of observing scRNA-seq reads from the droplet overlapping known SNPs. Demuxlet inferred the identities of cells in this study by analyzing each Cell Ranger-aligned BAM file from decidua and placenta in conjunction with a VCF containing the high-quality WGS variant calls from the corresponding mother and fetus (Supplementary Methods). Each droplet was assigned to be maternal, fetal, or unknown in 660 origin (ambiguous or potential doublet), and these identities were then linked with the transcriptome-based cell clustering data to confirm the maternal and fetal identity of each annotated cell type.
TCR analysis by TraCeR 665
The TCR sequences for each single T cell were assembled using TraCeR 68 which allowed the reconstruction of the TCRs from scRNA-seq data and their expression abundance (transcripts per million, TPM), as well as identification of the size, diversity and lineage relation of clonal subpopulations. In total, we obtained the TCR sequences for 1,482 T cells with at least one paired productive αβ or gamma-delta chain. Cells for which more than two recombinants 670 were identified for a particular locus were excluded from further analysis.
Quantification of KIR gene expression by KIRid
The KIR locus is characterized with high polymorphism both in the number of genes and alleles 9 . Including a single reference sequence for each gene can lead to reference bias for 675 donors that happen to match the reference sequence better. To address these issues, we used a tailored approach in which we mapped each donor's single cell reads to the corresponding donor-specific reference of KIR alleles, based on existing haplotypes.
Cell-cell communication analysis 680
To enable a comprehensive and systematic analysis of the cell-cell communication we have To assess the cellular crosstalk between different cell types, we used our repository in a statistical framework for inferring cell-cell communication networks from single cell transcriptome data. We derived potential receptor-ligand interactions based on expression of 695 a receptor by one cell type and a ligand by another cell type, using the high coverage SS2 data. In order to identify the most relevant interactions between cell types, we looked for the cell-type specific interactions between ligands and receptors. Only receptors and ligands expressed in more than 20% of the cells in the specific cluster were considered. First, we randomly permute the cluster labels of each cell 1000 times and determine the mean of the 700 average receptor expression level of a cluster and the average ligand expression level of the interacting cluster. For each receptor-ligand pair this generates a null distribution. By calculating the proportion of the means which are "as or more extreme" than actual mean, we obtain a p-value for the likelihood of cell type specificity of a given receptor-ligand pair. We then prioritized interactions that were highly specific based on the number of significant pairs 705 and manually selected biologically relevant ones. For the multi-subunit heteromeric complexes, the member of the complex with the minimum average expression is used for calculating the mean.
Data and materials availability 710
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